Business Context and Reporting Period
This Form 8-K is a current report filed by Agenus Inc. on August 10, 2026. The filing discloses a specific corporate governance event regarding executive compensation rather than routine financial reporting.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. The only financial data points disclosed relate to the specific terms of a stock option award:
- Option Exercise Price: $7.78 per share.
- Option Quantity: 1,971,500 performance-based stock options.
- Option Term: 10 years.
Material Changes
The material change reported is the approval of a special, one-time performance-based stock option award for Garo H. Armen, Ph.D., Chairman and CEO. Notably, the exercise price of $7.78 was set at a premium to the closing stock price on August 10, 2026, at Dr. Armen's request to align with grants made to other management team members on August 5, 2026.
Guidance, Outlook, and Risks
Performance Conditions: The award is divided into five equal tranches. Vesting is contingent upon the Company's stock price achieving and sustaining specific multiples of the $7.78 measurement price for 30 consecutive calendar days within a five-year performance period. The required multiples are 3x, 4x, 5x, 6x, and 8x.
Service and Forfeiture: A minimum three-year service requirement applies to each tranche. Unvested options are forfeited upon termination for any reason, including retirement or change in control, with no acceleration provisions. The Committee retains discretion regarding vesting in cases of death or disability.
Restrictions: Shares acquired upon exercise are generally subject to a one-year post-exercise holding requirement. The award is subject to the Company's clawback policy.
Investor Verification Checklist
- Verify the closing stock price of Agenus Inc. on August 10, 2026, to confirm the premium nature of the $7.78 exercise price.
- Review the Company's Amended and Restated 2019 Equity Incentive Plan to understand the broader context of this special award.
- Monitor future stock price performance against the 3x through 8x vesting thresholds over the next five years.
- Confirm the total number of shares reserved under the equity plan to assess potential dilution if these options vest.